Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Patience #7

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Apr 04, 2022 4:59pm

206 Views

Post# 34574637

RE:RE:Patience #7

I thought the GMP / ISO9001 pouch is supposedly very scalable, they have been saying that for years. Given they make multiple sizes for mice to primates to pigs to humans, I find it hard to beleive it would cost 200k to tweak the highly scalable pouch to make it a bit bigger let alone take a year to produce.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments